Volume 10, Issue 1

• Clinical News â?¦ antipsychotic drug developments â?¦ new clozapine monitoring program â?¦ antipsychotic use in dementia â?¦ antipsychotic exposure during pregnancy â?¦ omega-3 â?¦ mental illness and premature death â?¦ biomarkers â?¦ RAISE study â?¦ smart phones for schizophrenia â?¦
  Author(s): Peter F. Buckley
  • PDF
• Aspiration Pneumonia Due to ClozapineInduced Sialorrhea
  Author(s): Renee C. Saenger, Thomas H. Finch, Dimitry Francois
  • PDF
• Anhedonia of Patients with Schizophrenia and Schizoaffective Disorder is Attributed to Personality-Related Factors Rather than to State-Dependent Clinical Symptoms
  Author(s): Michael S. Ritsner
  • Abstract
  • PDF
• Aripiprazole-Induced Hypoprolactinemia in an Adult Male with First-Episode Psychosis
  Author(s): Alanna J. Propst, G. Eric Jarvis, Howard C. Margolese
  • Abstract
  • PDF
• Brexpiprazole for the Treatment of Schizophrenia: A Review of this Novel Serotonin-Dopamine Activity Modulator
  Author(s): Joseph McEvoy, Leslie Citrome
  • Abstract
  • PDF
• An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis
  Author(s): Ashok Malla, Pierre Chue, Gerald Jordan, Emmanuel Stip, David Koczerginski, Heather Milliken, Anil Joseph, Richard Williams, Beverly Adams, Rahul Manchanda, Kola Oyewumi, Marc-André Roy
  • Abstract
  • PDF